Cancer Biomarkers Market Share, Industry Size ,Growth Analysis And ForecastPosted by Neha Bora on January 21st, 2020 San Francisco, 21 January 2020: The Report Cancer Biomarkers Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2018 – 2025 The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers. In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to Cancer Biomarkers development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research. People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development. Access Research Report of Cancer Biomarkers Market @ www.grandviewresearch.com/industry-analysis/cancer-biomarker-market Further Key findings from the study suggest:
Grand View Research has segmented the cancer biomarkers market by type, biomolecule, applications, and region: Cancer Biomarkers Type Outlook (Revenue, USD Billion, 2014 - 2025)
Cancer Biomarkers Biomolecule Outlook (Revenue, USD Billion, 2014 - 2025)
Cancer Biomarkers Application Outlook (Revenue, USD Billion, 2014 - 2025)
Cancer Biomarkers Regional Outlook (Revenue, USD Billion, 2014 - 2025)
Like it? Share it!More by this author |